Skip to main content
Join CMKC members for a complimentary virtual event on December 10, 11am ET: CM MythBusters: https://bit.ly/3YXJynA. This is a fantastic opportunity to connect, collaborate, and debunk common myths about continuous manufacturing!
3.15.228.171

Pharmaceutical industry perspectives on flow chemocatalysis and biocatalysis

By Martin, LL; Peschke, TVenturoni, F; Mostarda, S

Published on

Abstract

In response to a growing demand for more sustainable and cost-effective synthetic processes, the pharmaceutical industry is increasingly relying on continuous manufacturing as a valuable alternative to conventional batch processing. Particularly, flow processing may enable process intensification of chemocatalytic and biocatalytic transformations, both being of strategic importance on the design and production of active pharmaceutical ingredients. This review outlines the current status of flow chemocatalysis and biocatalysis within the pharmaceutical landscape. Furthermore, the trends and challenges that these technologies face are highlighted, based on recently disclosed applications from industry and innovative solutions from academia.

Journal

Current Opinion in Green and Sustainable Chemistry. Volume 25, 2020

DOI

10.1016/j.cogsc.2020.04.011

Type of publication

Peer-reviewed journal

Affiliations

  • Novartis Pharma AG

Article Classification

Review article

Classification Areas

  • API

Tags